Gabriela Pacheco Sanchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gabriela Pacheco Sanchez has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Dequina A. Nicholas
Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California Irvine, Irvine, CA, United States
4 shared publications - Simone Baldini Lucheis
Tropical Diseases and Image Diagnosis Department, Medical College, Sao Paulo State University (UNESP), Botucatu, Brazil; Animal Production and Preventive Veterinary Medicine Department (FMVZ), Sao Paulo State University (UNESP), Botucatu, Brazil
4 shared publications Gabriela De Robles
University of California Irvine Department of Molecular Biology and Biochemistry, School of Biological Sciences Irvine, CA
3 shared publications- Lívia Maísa Guiraldi
Universidade Estadual Paulista Júlio de Mesquita Filho
3 shared publications - Maria Fernanda Alves-Martin
Departamento de Produção Animal e Medicina Veterinária Preventiva, FMVZ-UNESP, Botucatu, SP
3 shared publications - Mirian dos Santos Paixão-Marques
Department of Tropical Diseases, Botucatu Medical School, Sao Paulo State University (UNESP), Botucatu 18603-560, SP, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 172 (1)
Toll-like Receptor 4 Knockout Mice are Protected Against PMOS-like Pathogenesis
Polyendocrine metabolic ovarian syndrome (PMOS), formerly termed polycystic ovary syndrome (PCOS), is a reproductive disorder with heterogeneous symptoms and severity. Despite extensive research documenting chronic immune dysfunction as a hallmark of PMOS, the specific mechanisms of immune activation remain poorly understood. Emerging evidence suggests that gut-derived bacterial endotoxins, particularly lipopolysaccharide (LPS), can breach intestinal barriers and trigger systemic inflammation via Toll-like receptor 4 (TLR4). This study examined the role of TLR4 in PMOS-like pathology using a letrozole (LET)-induced mouse model. In LET-treated wild-type female mice, serum LPS and its carrier protein LBP were elevated compared to LET-treated TLR4-/- mice. Additionally, TLR4 deficiency attenuated multiple PMOS-like features, including elevated luteinizing hormone, anovulation, and metabolic dysfunction. LET-treated TLR4-/- mice also preserved estrous cycling and fertility, maintained gut barrier integrity, and reduced inflammatory markers. These findings support TLR4 as an important contributor to multiple features of PMOS-like pathology. This novel work highlights TLR4-mediated inflammation as a potential target for anti-inflammatory treatments in women with PMOS.
- 1 July 2026
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 172 (1)
Open AccessToll-like Receptor 4 Knockout Mice are Protected Against PMOS-like Pathogenesis
Polyendocrine metabolic ovarian syndrome (PMOS), formerly termed polycystic ovary syndrome (PCOS), is a reproductive disorder with heterogeneous symptoms and severity. Despite extensive research documenting chronic immune dysfunction as a hallmark of PMOS, the specific mechanisms of immune activation remain poorly understood. Emerging evidence suggests that gut-derived bacterial endotoxins, particularly lipopolysaccharide (LPS), can breach intestinal barriers and trigger systemic inflammation via Toll-like receptor 4 (TLR4). This study examined the role of TLR4 in PMOS-like pathology using a letrozole (LET)-induced mouse model. In LET-treated wild-type female mice, serum LPS and its carrier protein LBP were elevated compared to LET-treated TLR4-/- mice. Additionally, TLR4 deficiency attenuated multiple PMOS-like features, including elevated luteinizing hormone, anovulation, and metabolic dysfunction. LET-treated TLR4-/- mice also preserved estrous cycling and fertility, maintained gut barrier integrity, and reduced inflammatory markers. These findings support TLR4 as an important contributor to multiple features of PMOS-like pathology. This novel work highlights TLR4-mediated inflammation as a potential target for anti-inflammatory treatments in women with PMOS.
- Open Access
- 26 September 2025
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 13 (6) , 5008-5024
Comparative Analysis of White and African American Groups Reveals Unique Lipid and Inflammatory Features of Diabetes
Diabetes is a metabolic and inflammatory disease that disproportionately affects African American populations, yet clinical diagnostics often rely on biomarkers discovered and validated predominantly in White cohorts. This study investigates race-specific lipid and inflammatory features of diabetes to uncover biologically distinct disease signatures that may contribute to disparities in diagnosis and management. We analyzed clinical parameters from a well-matched subset of the HANDLS cohort ( N = 40) and conducted targeted plasma lipidomics and multiplex cytokine profiling across African American and White individuals from the HANDLS cohort with and without diabetes. Then we validated key findings using a large and diverse cohort of African American and White individuals with type 2 diabetes from the NIH AllofUs program ( N = 17,339). Our results reveal racially divergent signatures of diabetes. White individuals with diabetes exhibited elevated Cholesterol:HDL ratios, triglycerides, and classical inflammatory markers such as hs-CRP. In contrast, African American individuals with diabetes displayed minimal lipid elevations but showed increased Th17-related cytokines1. These differences were independent of statin use, age, and body mass index. Additionally, correlations between lipid to cytokine ratios and the glycemic marker hemoglobin A1C differed sharply by race, suggesting that the pathophysiology of diabetes is not uniform across populations. Our findings challenge standard diabetes biomarkers and emphasize the need for more inclusive diagnostic frameworks. By identifying population-specific biological patterns of diabetes, this study provides important insight into the roots of persistent health disparities and underscores the value of precision approaches to equitable diabetes care.
- 26 September 2025
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 13 (6) , 5008-5024
Open AccessComparative Analysis of White and African American Groups Reveals Unique Lipid and Inflammatory Features of Diabetes
Diabetes is a metabolic and inflammatory disease that disproportionately affects African American populations, yet clinical diagnostics often rely on biomarkers discovered and validated predominantly in White cohorts. This study investigates race-specific lipid and inflammatory features of diabetes to uncover biologically distinct disease signatures that may contribute to disparities in diagnosis and management. We analyzed clinical parameters from a well-matched subset of the HANDLS cohort ( N = 40) and conducted targeted plasma lipidomics and multiplex cytokine profiling across African American and White individuals from the HANDLS cohort with and without diabetes. Then we validated key findings using a large and diverse cohort of African American and White individuals with type 2 diabetes from the NIH AllofUs program ( N = 17,339). Our results reveal racially divergent signatures of diabetes. White individuals with diabetes exhibited elevated Cholesterol:HDL ratios, triglycerides, and classical inflammatory markers such as hs-CRP. In contrast, African American individuals with diabetes displayed minimal lipid elevations but showed increased Th17-related cytokines1. These differences were independent of statin use, age, and body mass index. Additionally, correlations between lipid to cytokine ratios and the glycemic marker hemoglobin A1C differed sharply by race, suggesting that the pathophysiology of diabetes is not uniform across populations. Our findings challenge standard diabetes biomarkers and emphasize the need for more inclusive diagnostic frameworks. By identifying population-specific biological patterns of diabetes, this study provides important insight into the roots of persistent health disparities and underscores the value of precision approaches to equitable diabetes care.
- Open Access
- 22 September 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , 656-664
Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome
Context: Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with chronic inflammation, but comprehensive characterization of immune markers across diverse patient populations is lacking. Objective: To determine whether PCOS exhibits a profile of chronic inflammation or immune dysregulation when analyzed across a diverse patient population. Design: Retrospective cross-sectional study of samples collected between 1987 and 2010 as part of the Androgen Excess Biorepository. Setting: Reproductive endocrinology clinics at the University of Alabama at Birmingham in Birmingham, Alabama, and Cedars-Sinai Medical Center in Los Angeles, California, where women and adolescents presented for evaluation of androgen excess. Patients: Forty premenopausal women (20 with PCOS, 20 controls) aged 18 to 45 years, categorized by race (Black and White) and PCOS diagnosis. Participants were race, age, and body mass index matched. Main Outcome Measures: Fasted follicular phase plasma concentrations of C-reactive protein and 96 circulating immune markers, including interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-18, measured using a Milliplex Luminex xMAP assay. Results: PCOS patients showed significantly lower levels of circulating immune markers (P < .05). Growth factors (vascular endothelial growth factor A, platelet-derived growth factor), proinflammatory cytokines (IL-8, TNF-α, interferon-γ), and several chemokines were reduced in PCOS patients, independent of race. Only IL-18 and C-X-C motif chemokine ligand 16 showed statistically significant differences between Black and White women. Conclusion: This study challenges the prevailing notion of PCOS as a disorder of chronic low-grade inflammation, suggesting instead that immune suppression and impaired angiogenic signaling may be factors in PCOS pathophysiology, especially in nonobese patients. Further research with larger sample sizes and inclusion of metabolic metrics is needed to confirm these findings before they can be applied in clinical practice.
- 22 September 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , 656-664
Open AccessMultiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome
Context: Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with chronic inflammation, but comprehensive characterization of immune markers across diverse patient populations is lacking. Objective: To determine whether PCOS exhibits a profile of chronic inflammation or immune dysregulation when analyzed across a diverse patient population. Design: Retrospective cross-sectional study of samples collected between 1987 and 2010 as part of the Androgen Excess Biorepository. Setting: Reproductive endocrinology clinics at the University of Alabama at Birmingham in Birmingham, Alabama, and Cedars-Sinai Medical Center in Los Angeles, California, where women and adolescents presented for evaluation of androgen excess. Patients: Forty premenopausal women (20 with PCOS, 20 controls) aged 18 to 45 years, categorized by race (Black and White) and PCOS diagnosis. Participants were race, age, and body mass index matched. Main Outcome Measures: Fasted follicular phase plasma concentrations of C-reactive protein and 96 circulating immune markers, including interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-18, measured using a Milliplex Luminex xMAP assay. Results: PCOS patients showed significantly lower levels of circulating immune markers (P < .05). Growth factors (vascular endothelial growth factor A, platelet-derived growth factor), proinflammatory cytokines (IL-8, TNF-α, interferon-γ), and several chemokines were reduced in PCOS patients, independent of race. Only IL-18 and C-X-C motif chemokine ligand 16 showed statistically significant differences between Black and White women. Conclusion: This study challenges the prevailing notion of PCOS as a disorder of chronic low-grade inflammation, suggesting instead that immune suppression and impaired angiogenic signaling may be factors in PCOS pathophysiology, especially in nonobese patients. Further research with larger sample sizes and inclusion of metabolic metrics is needed to confirm these findings before they can be applied in clinical practice.
- Open Access
Comparative analysis of White and African American groups reveals unique lipid and inflammatory features of diabetes
Importance: African Americans have a higher prevalence of Type 2 Diabetes (T2D) compared to White groups. T2D is a health disparity clinically characterized by dysregulation of lipids and chronic inflammation. However, how the relationships among biological and sociological predictors of T2D drive this disparity remains to be addressed. Objective: To determine characteristic plasma lipids and systemic inflammatory biomarkers contributing to diabetes presentation between White and African American groups. Design: We performed a cross-sectional retrospective cohort study using pre-existing demographic and clinical data from two diverse studies: Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) and AllofUs. From HANDLS (N=40), we used information from wave 1 (2004). From AllofUs (N=17,339), we used data from the Registered Tier Dataset v7, available in the AllofUs researcher workbench. Setting: HANDLS is a population-based cohort study involving 3720 participants in the Baltimore area supported by the Intramural Research Program of the National Institute on Aging. HANDLS is a longitudinal study designed to understand the sources of persistent health disparities in overall longevity and chronic disease in White and African American individuals. The AllofUs study is an NIH funded multicenter study consisting of patient-level data from 331,382 individuals from 35 hospitals in the United States aimed at sampling one million or more people living in the United States to provide a collection of broadly accessible data. Participants: The HANDLS subcohort participants (N=40) were divided into four groups equally distributed by race, sex, and diabetes status. Groups were also matched by age, body mass index, and poverty status. The analysis pipeline consisted of evaluating the significance of the variables race and disease status using the 2-way ANOVA test and post-ANOVA comparisons using Fisher LSD test, reporting unadjusted p-values. Additionally, unsupervised (PCA) and supervised (OPLS-DA) clustering analysis was performed to determine putative biological drivers of variability and main immunological and metabolic features characterizing diabetes in White and African American groups from HANDLS. Major clinical findings were validated in a large cohort of White and African American groups with T2D in the AllofUS research study (N=17,339). AllofUs groups were of similar range in age and BMI as HANDLS. Furthermore, a linear regression model was built adjusting for age and BMI to determine differences in clinical findings between White and African American groups with T2D. Main Outcomes and Measures: Primary outcomes using a HANDLS subcohort (N=40) were clinical parameters related to diabetes, plasma lipids determined by lipidomics and measured by mass spectrometry, and cytokine profiling using a customized panel of 52 cytokines and growth factors measured by Luminex. Outcomes evaluated in the AllofUs study (N=17,339) were clinical: cholesterol to HDL ratio, triglycerides, fasting glucose, insulin, and hemoglobin A1C. Results: In the HANDLS subcohort, White individuals with diabetes had elevated cholesterol to HDL ratio (mean difference -1.869, p =0.0053 ) , high-sensitivity C-reactive protein (mean difference -9.135, p =0.0040), and clusters of systemic triglycerides measured by lipidomics, compared to White individuals without diabetes. These clinical markers of dyslipidemia (cholesterol to HDL ratio and triglycerides) and inflammation (hs-CRP) were not significantly elevated in diabetes in African Americans from the HANDLS subcohort. These results persisted even when controlling for statin use. Diabetes in White individuals in the HANDLS cohort was characterized by a marked elevation in plasma lipids, while an inflammatory status characterized by Th17-cytokines was predominant in the African American group from the HANDLS subcohort. We validated the key findings of elevated triglycerides and cholesterol to HDL ratio in White individuals with T2D in a sample (N=17,339) of the AllofUs study. Conclusions and Relevance: Our results show that diabetes can manifest with healthy lipid profiles, particularly in these cohorts of African Americans. This study suggests that Th17-inflammation associated with diabetes is characteristic of African Americans, while a more classic inflammation is distinctive of White individuals from HANDLS cohort. Further, clinical markers of dyslipidemia seem to characterize diabetes presentation only in White groups, and not in African Americans.
Open AccessComparative analysis of White and African American groups reveals unique lipid and inflammatory features of diabetes
Importance: African Americans have a higher prevalence of Type 2 Diabetes (T2D) compared to White groups. T2D is a health disparity clinically characterized by dysregulation of lipids and chronic inflammation. However, how the relationships among biological and sociological predictors of T2D drive this disparity remains to be addressed. Objective: To determine characteristic plasma lipids and systemic inflammatory biomarkers contributing to diabetes presentation between White and African American groups. Design: We performed a cross-sectional retrospective cohort study using pre-existing demographic and clinical data from two diverse studies: Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) and AllofUs. From HANDLS (N=40), we used information from wave 1 (2004). From AllofUs (N=17,339), we used data from the Registered Tier Dataset v7, available in the AllofUs researcher workbench. Setting: HANDLS is a population-based cohort study involving 3720 participants in the Baltimore area supported by the Intramural Research Program of the National Institute on Aging. HANDLS is a longitudinal study designed to understand the sources of persistent health disparities in overall longevity and chronic disease in White and African American individuals. The AllofUs study is an NIH funded multicenter study consisting of patient-level data from 331,382 individuals from 35 hospitals in the United States aimed at sampling one million or more people living in the United States to provide a collection of broadly accessible data. Participants: The HANDLS subcohort participants (N=40) were divided into four groups equally distributed by race, sex, and diabetes status. Groups were also matched by age, body mass index, and poverty status. The analysis pipeline consisted of evaluating the significance of the variables race and disease status using the 2-way ANOVA test and post-ANOVA comparisons using Fisher LSD test, reporting unadjusted p-values. Additionally, unsupervised (PCA) and supervised (OPLS-DA) clustering analysis was performed to determine putative biological drivers of variability and main immunological and metabolic features characterizing diabetes in White and African American groups from HANDLS. Major clinical findings were validated in a large cohort of White and African American groups with T2D in the AllofUS research study (N=17,339). AllofUs groups were of similar range in age and BMI as HANDLS. Furthermore, a linear regression model was built adjusting for age and BMI to determine differences in clinical findings between White and African American groups with T2D. Main Outcomes and Measures: Primary outcomes using a HANDLS subcohort (N=40) were clinical parameters related to diabetes, plasma lipids determined by lipidomics and measured by mass spectrometry, and cytokine profiling using a customized panel of 52 cytokines and growth factors measured by Luminex. Outcomes evaluated in the AllofUs study (N=17,339) were clinical: cholesterol to HDL ratio, triglycerides, fasting glucose, insulin, and hemoglobin A1C. Results: In the HANDLS subcohort, White individuals with diabetes had elevated cholesterol to HDL ratio (mean difference -1.869, p =0.0053 ) , high-sensitivity C-reactive protein (mean difference -9.135, p =0.0040), and clusters of systemic triglycerides measured by lipidomics, compared to White individuals without diabetes. These clinical markers of dyslipidemia (cholesterol to HDL ratio and triglycerides) and inflammation (hs-CRP) were not significantly elevated in diabetes in African Americans from the HANDLS subcohort. These results persisted even when controlling for statin use. Diabetes in White individuals in the HANDLS cohort was characterized by a marked elevation in plasma lipids, while an inflammatory status characterized by Th17-cytokines was predominant in the African American group from the HANDLS subcohort. We validated the key findings of elevated triglycerides and cholesterol to HDL ratio in White individuals with T2D in a sample (N=17,339) of the AllofUs study. Conclusions and Relevance: Our results show that diabetes can manifest with healthy lipid profiles, particularly in these cohorts of African Americans. This study suggests that Th17-inflammation associated with diabetes is characteristic of African Americans, while a more classic inflammation is distinctive of White individuals from HANDLS cohort. Further, clinical markers of dyslipidemia seem to characterize diabetes presentation only in White groups, and not in African Americans.
- Open Access
Detection of Leishmania spp. in Cats: Analysis of Nasal, Oral and Conjunctival Swabs by PCR and HRM
Background and objectives: Feline leishmaniasis (FeL) is caused by several species of parasites of the genus Leishmania. The disease can occur with the presence or absence of clinical signs, similar to those observed in other common infectious diseases. In endemic regions for FeL, the infection has been associated with dermatological lesions. Therefore, considering the search for less invasive and more effective diagnostic techniques, we aimed to investigate the presence of Leishmania spp. in domestic cats through Polymerase Chain Reaction (PCR) and high-resolution melting (HRM) analyses of conjunctival, oral, and nasal epithelial cells, and we detected the presence of anti-Leishmania IgG antibodies from serological techniques of the Immunofluorescent Antibody Test (IFAT) and ELISA. Methods: The PCR and HRM for detection of Leishmania spp. were performed on 36 samples of epithelial cells from the conjunctiva of male and female cats, collected using sterile swabs. The serological tests IFAT and ELISA were also performed. Results: The prevalence of Leishmania donovani infection was 11.1% (4/36) by PCR assay, and those results were confirmed for Leishmania species using the HRM technique. Twenty-four cats (24/36 = 66.7%) were reactive to the IFAT and twenty-two cats were reactive by the ELISA technique (22/36 = 61.1%). Interpretation and Conclusions: The use of conjunctival swabs was shown to be a non-invasive, practical, and easy-to-perform technique, and in addition to the genetic sequencing and HRM, it was able to identify the parasitic DNA of L. donovani in cats. This technique can be used for screening diagnosis in future epidemiological surveys of FeL and can be used as a complement to clinical and/or serological tests, as well as associating the clinical history of the animal, for the diagnostic conclusion.
Open AccessDetection of Leishmania spp. in Cats: Analysis of Nasal, Oral and Conjunctival Swabs by PCR and HRM
Background and objectives: Feline leishmaniasis (FeL) is caused by several species of parasites of the genus Leishmania. The disease can occur with the presence or absence of clinical signs, similar to those observed in other common infectious diseases. In endemic regions for FeL, the infection has been associated with dermatological lesions. Therefore, considering the search for less invasive and more effective diagnostic techniques, we aimed to investigate the presence of Leishmania spp. in domestic cats through Polymerase Chain Reaction (PCR) and high-resolution melting (HRM) analyses of conjunctival, oral, and nasal epithelial cells, and we detected the presence of anti-Leishmania IgG antibodies from serological techniques of the Immunofluorescent Antibody Test (IFAT) and ELISA. Methods: The PCR and HRM for detection of Leishmania spp. were performed on 36 samples of epithelial cells from the conjunctiva of male and female cats, collected using sterile swabs. The serological tests IFAT and ELISA were also performed. Results: The prevalence of Leishmania donovani infection was 11.1% (4/36) by PCR assay, and those results were confirmed for Leishmania species using the HRM technique. Twenty-four cats (24/36 = 66.7%) were reactive to the IFAT and twenty-two cats were reactive by the ELISA technique (22/36 = 61.1%). Interpretation and Conclusions: The use of conjunctival swabs was shown to be a non-invasive, practical, and easy-to-perform technique, and in addition to the genetic sequencing and HRM, it was able to identify the parasitic DNA of L. donovani in cats. This technique can be used for screening diagnosis in future epidemiological surveys of FeL and can be used as a complement to clinical and/or serological tests, as well as associating the clinical history of the animal, for the diagnostic conclusion.
- Open Access
- 9 February 2022
- Published by Revista Veterinaria e Zootecnia in Veterinária e Zootecnia
- Vol. 29, 1-18
OCORRÊNCIA DA INFECÇÃO NATURAL PARA Leishmania spp. NA POPULAÇÃO CANINA DOMICILIADA E HUMANA DE TRÊS LAGOAS-MS E ANÁLISE ESPACIAL
A Leishmaniose Visceral (LV), doença negligenciada de caráter crônico e sistêmico, causada pelo parasita Leishmania spp. representa um problema de saúde pública, principalmente em países com população vulnerável, como o Brasil. Devido à urbanização de grandes centros, cães configuram um importante reservatório no ciclo urbano, precedendo casos humanos e contribuindo para a manutenção de casos de Leishmaniose Visceral Canina (LVC). Entretanto, poucos inquéritos sorológicos somados à analise espacial envolvendo a população humana e animal foram descritos no município de Três Lagoas. Diante disso, o objetivo do estudo foi identificar e descrever a ocorrência da infecção natural por Leishmania spp. na população canina domiciliada e humana de Três Lagoas – MS, Brasil, utilizando-se das técnicas sorológicas de Dual Path Platform (DPP), Enzyme Linked Immunosorbent Assay (ELISA) e Reação de Imunofluorescência Indireta (RIFI), bem como molecular para Leishmania spp. e análise por georreferenciamento. Para isso, foram coletadas 566 amostras sanguíneas de cães. Além disso, informações epidemiológicas adicionais foram coletadas do sistema de saúde do município, e posteriormente, a análise espacial foi realizada. Como resultados obteve-se 267 amostras reagentes ao teste DPP, 267 amostras reagentes ao ELISA e 97 à RIFI, com 95% de concordância entre os métodos DPP e ELISA. Das amostras submetidas à PCR, 16 foram positivas para Leishmania spp. O uso do georreferenciamento para LVC canina em Três Lagoas forneceu subsídios para identificar áreas com prioridade de intervenção para o controle da doença. A presença de flebotomíneos, associado à localização geográfica, bem como às condições ambientais na região estudada, foram favoráveis à sua disseminação, bem como à transmissão da doença aos cães e a humanos.
- 9 February 2022
- Published by Revista Veterinaria e Zootecnia in Veterinária e Zootecnia
- Vol. 29, 1-18
Open AccessOCORRÊNCIA DA INFECÇÃO NATURAL PARA Leishmania spp. NA POPULAÇÃO CANINA DOMICILIADA E HUMANA DE TRÊS LAGOAS-MS E ANÁLISE ESPACIAL
A Leishmaniose Visceral (LV), doença negligenciada de caráter crônico e sistêmico, causada pelo parasita Leishmania spp. representa um problema de saúde pública, principalmente em países com população vulnerável, como o Brasil. Devido à urbanização de grandes centros, cães configuram um importante reservatório no ciclo urbano, precedendo casos humanos e contribuindo para a manutenção de casos de Leishmaniose Visceral Canina (LVC). Entretanto, poucos inquéritos sorológicos somados à analise espacial envolvendo a população humana e animal foram descritos no município de Três Lagoas. Diante disso, o objetivo do estudo foi identificar e descrever a ocorrência da infecção natural por Leishmania spp. na população canina domiciliada e humana de Três Lagoas – MS, Brasil, utilizando-se das técnicas sorológicas de Dual Path Platform (DPP), Enzyme Linked Immunosorbent Assay (ELISA) e Reação de Imunofluorescência Indireta (RIFI), bem como molecular para Leishmania spp. e análise por georreferenciamento. Para isso, foram coletadas 566 amostras sanguíneas de cães. Além disso, informações epidemiológicas adicionais foram coletadas do sistema de saúde do município, e posteriormente, a análise espacial foi realizada. Como resultados obteve-se 267 amostras reagentes ao teste DPP, 267 amostras reagentes ao ELISA e 97 à RIFI, com 95% de concordância entre os métodos DPP e ELISA. Das amostras submetidas à PCR, 16 foram positivas para Leishmania spp. O uso do georreferenciamento para LVC canina em Três Lagoas forneceu subsídios para identificar áreas com prioridade de intervenção para o controle da doença. A presença de flebotomíneos, associado à localização geográfica, bem como às condições ambientais na região estudada, foram favoráveis à sua disseminação, bem como à transmissão da doença aos cães e a humanos.
- Open Access
- 10 December 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-14
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen are effective in treating adults and children with B-cell malignancies. Place-of-care manufacturing may improve performance and accessibility by obviating the need to cryopreserve and transport cells to centralized facilities. Here we develop an anti-CD19 CAR (CAR19) comprised of the 4-1BB co-stimulatory and TNFRSF19 transmembrane domains, showing anti-tumor efficacy in an in vivo xenograft lymphoma model. CAR19 T cells are manufactured under current good manufacturing practices (cGMP) at two disparate clinical sites, Moscow (Russia) and Cleveland (USA). The CAR19 T-cells is used to treat patients with relapsed/refractory pediatric B-cell Acute Lymphocytic Leukemia (ALL; n = 31) or adult B-cell Lymphoma (NHL; n = 23) in two independently conducted phase I clinical trials with safety as the primary outcome (NCT03467256 and NCT03434769, respectively). Probability of measurable residual disease-negative remission was also a primary outcome in the ALL study. Secondary outcomes include complete remission (CR) rates, overall survival and median duration of response. CR rates are 89% (ALL) and 73% (NHL). After a median follow-up of 17 months, one-year survival rate of ALL complete responders is 79.2% (95%CI 64.5‒97.2%) and median duration of response is 10.2 months. For NHL complete responders one-year survival is 92.9%, and median duration of response has not been reached. Place-of-care manufacturing produces consistent CAR-T cell products at multiple sites that are effective for the treatment of patients with B-cell malignancies.
- 10 December 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-14
Open AccessMultiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen are effective in treating adults and children with B-cell malignancies. Place-of-care manufacturing may improve performance and accessibility by obviating the need to cryopreserve and transport cells to centralized facilities. Here we develop an anti-CD19 CAR (CAR19) comprised of the 4-1BB co-stimulatory and TNFRSF19 transmembrane domains, showing anti-tumor efficacy in an in vivo xenograft lymphoma model. CAR19 T cells are manufactured under current good manufacturing practices (cGMP) at two disparate clinical sites, Moscow (Russia) and Cleveland (USA). The CAR19 T-cells is used to treat patients with relapsed/refractory pediatric B-cell Acute Lymphocytic Leukemia (ALL; n = 31) or adult B-cell Lymphoma (NHL; n = 23) in two independently conducted phase I clinical trials with safety as the primary outcome (NCT03467256 and NCT03434769, respectively). Probability of measurable residual disease-negative remission was also a primary outcome in the ALL study. Secondary outcomes include complete remission (CR) rates, overall survival and median duration of response. CR rates are 89% (ALL) and 73% (NHL). After a median follow-up of 17 months, one-year survival rate of ALL complete responders is 79.2% (95%CI 64.5‒97.2%) and median duration of response is 10.2 months. For NHL complete responders one-year survival is 92.9%, and median duration of response has not been reached. Place-of-care manufacturing produces consistent CAR-T cell products at multiple sites that are effective for the treatment of patients with B-cell malignancies.
- Open Access
- 8 June 2021
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 50 (2) , 121-134
TRYPANOSOMA spp. in captive primates in a brazilian zoo
Captive animals, despite the constant care provided, are susceptible to infections from different sources. We herein report the natural trypanosome infection of 11 (28.2% positive) out of 39 non-human primates from 13 different species, in a Brazilian zoological park. Immunofluorescent antibody test (IFAT) and conventional polymerase chain reaction (cPCR) ruled out Trypanosoma cruzi, the etiological agent of Chagas disease. However, sequencing performed with positive samples employing hsp70 primers revealed similarities from 86% to 88% to diverse trypanosomes, including T. cruzi, Trypanosoma grayi, Trypanosoma lewisi, Trypanosoma rangeli and Trypanosoma vivax. We believe that the low similarity values obtained by sequencing reflect the difficulties in the molecular identification of trypanosomes, which share a large portion of their genetic material; this similarity may also preclude the diagnosis of co-infection by more than one trypanosome species. Thus, our study demonstrates the presence of diverse trypanosomes in primates, which are susceptible to infection by these parasites. Mechanical devices such as windows and bed nets, etc., are required to avoid vector insects in these environments, in addition to preventive quarantining of animals recently introduced into zoos. Therefore, investigation of the parasites in both the animals already residing in the zoo and those being introduced is of paramount importance, although no easy task. KEY WORDS: Non-human primates; monkey; diagnosis; trypanosomes.
- 8 June 2021
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 50 (2) , 121-134
Open AccessTRYPANOSOMA spp. in captive primates in a brazilian zoo
Captive animals, despite the constant care provided, are susceptible to infections from different sources. We herein report the natural trypanosome infection of 11 (28.2% positive) out of 39 non-human primates from 13 different species, in a Brazilian zoological park. Immunofluorescent antibody test (IFAT) and conventional polymerase chain reaction (cPCR) ruled out Trypanosoma cruzi, the etiological agent of Chagas disease. However, sequencing performed with positive samples employing hsp70 primers revealed similarities from 86% to 88% to diverse trypanosomes, including T. cruzi, Trypanosoma grayi, Trypanosoma lewisi, Trypanosoma rangeli and Trypanosoma vivax. We believe that the low similarity values obtained by sequencing reflect the difficulties in the molecular identification of trypanosomes, which share a large portion of their genetic material; this similarity may also preclude the diagnosis of co-infection by more than one trypanosome species. Thus, our study demonstrates the presence of diverse trypanosomes in primates, which are susceptible to infection by these parasites. Mechanical devices such as windows and bed nets, etc., are required to avoid vector insects in these environments, in addition to preventive quarantining of animals recently introduced into zoos. Therefore, investigation of the parasites in both the animals already residing in the zoo and those being introduced is of paramount importance, although no easy task. KEY WORDS: Non-human primates; monkey; diagnosis; trypanosomes.
- Open Access
Complete diagnosis of leptospirosis in tropical reproductive cattle
Leptospirosis is a worlwide zoonosis of great impact in both animal and public health. Bovine leptospirosis is commonly manifested by reproductive disorders, such as abortion, stillbirth and infertility; causing depletion of the economic balance of livestock farms, along with representing a health risk problem for farm workers. In view of these consequences, we aimed to evaluate the sanitary status of tropical cattle and their role as reproductive disseminators of leptospirosis. We analyzed blood and semen samples from 11 brazilian herds by three diagnostic methods -Culture, Microscopic Agglutination Test and Polymerase Chain Reaction. All animals were negative for bacteriological culture in Fletcher’s semisolid medium; 66% (264/400) animals were seropositive to at least one of 19 serovars (17 serogroups) of Leptospira spp. by MAT, given that 42.4% and 5.3% of animals presented titers against brazilians isolates Guaricura and Nupezo, respectively; furthermore, five animals were positive by PCR in blood and/or culture samples and three semen samples were positive by PCR (one of them also seropositive). These results highlight the coexistence of both disease's stages (acute and chronic) in the same environment, thus alert for venereal dissemination of leptospirosis, aggravating their sanitary condition and fomenting economic losses. We, authors, recommend the adoption of prophylactic measures, such as systemic vaccination, treatment of animals and improvement of hygienic-sanitary conditions.
Open AccessComplete diagnosis of leptospirosis in tropical reproductive cattle
Leptospirosis is a worlwide zoonosis of great impact in both animal and public health. Bovine leptospirosis is commonly manifested by reproductive disorders, such as abortion, stillbirth and infertility; causing depletion of the economic balance of livestock farms, along with representing a health risk problem for farm workers. In view of these consequences, we aimed to evaluate the sanitary status of tropical cattle and their role as reproductive disseminators of leptospirosis. We analyzed blood and semen samples from 11 brazilian herds by three diagnostic methods -Culture, Microscopic Agglutination Test and Polymerase Chain Reaction. All animals were negative for bacteriological culture in Fletcher’s semisolid medium; 66% (264/400) animals were seropositive to at least one of 19 serovars (17 serogroups) of Leptospira spp. by MAT, given that 42.4% and 5.3% of animals presented titers against brazilians isolates Guaricura and Nupezo, respectively; furthermore, five animals were positive by PCR in blood and/or culture samples and three semen samples were positive by PCR (one of them also seropositive). These results highlight the coexistence of both disease's stages (acute and chronic) in the same environment, thus alert for venereal dissemination of leptospirosis, aggravating their sanitary condition and fomenting economic losses. We, authors, recommend the adoption of prophylactic measures, such as systemic vaccination, treatment of animals and improvement of hygienic-sanitary conditions.
- Open Access
- 27 January 2016
- Published by Springer Nature in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 22 (1) , 1-4
Anti-leptospirosis agglutinins in Brazilian capybaras (Hydrochoerus hydrochaeris)
The interest in commercial use of wild animals is increasing, especially regarding raising of capybaras. Although this wild species is potentially lucrative for the production of meat, oil and leather, it is suggested as a probable reservoir of leptospires.
- 27 January 2016
- Published by Springer Nature in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 22 (1) , 1-4
Open AccessAnti-leptospirosis agglutinins in Brazilian capybaras (Hydrochoerus hydrochaeris)
The interest in commercial use of wild animals is increasing, especially regarding raising of capybaras. Although this wild species is potentially lucrative for the production of meat, oil and leather, it is suggested as a probable reservoir of leptospires.